Welcome to the Newsroom

From the latest health and nutrition solutions to making an impact on people and the planet, check out our top stories. To contact our U.S. media relations team, please email nhscusmedia@us.nestle.com

All Stories Press Releases Product News Our People Diversity, Equity and Inclusion Innovation Sustainability Community Impact

Seres Therapeutics and Nestlé Health Science Present Results from ECOSPOR IV Phase 3 Study of VOWST™ a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

Learn More

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI

Learn More

Orgain Earns B Corp™ Certification

Learn More

Seres Therapeutics and Nestlé Health Science Present Results from ECOSPOR IV Phase 3 Study of VOWST™ a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

May 08, 2023

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI

April 26, 2023

Orgain Earns B Corp™ Certification

March 16, 2023

Innovation on Display at Natural Products Expo West 2023

March 14, 2023

Women in Science Encourage Next Generation of Female Leaders

February 11, 2023

Crohn’s & Colitis Foundation and Nestlé Health Science Launch Digital Recipe Tool Powered by Nutrition Insights and Machine-Learning

February 01, 2023

Send a media inquiry

Connect with our Media Relations team.